I like to keep an eye on new technology that can be useful for ME patients. And this time I found ALPE.
ALPE (Automatic Lung Parameter Estimation) is a product from Mermaid Care in Denmark. Their vision is:
“to make ALPE (Automatic Lung Parameter Estimation) the International Clinical Standard for diagnosing and characterizing the Pulmonary Gas Exchange. Our expertise in Pulmonary Gas Exchange Diagnostic is helping healthcare professionals in new ways to predict, diagnose and treat disease.”´
ALPE essential characterizes the pulmonary gas exchange and is used to minimize and document pulmonary complications during the anesthesia process. It makes an optimal preoperative pulmonary diagnostic for patients with shortness of breath.
ME patients have Diminished Cardiopulmonary Capacity During Post-Exertional Malaise (PEM).
Workwell Foundation uses cardiopulmonary exercise testing (CPET) in ME diagnostic.
Snell et al. have recently publiced this article on the subject: Discriminative Validity of Metabolic and Workload Measurements to Identify Individuals With Chronic Fatigue Syndrome
And ME patients are frequently in a state of PEM. Furthermore ME patients don’t tolerate Anesthesia very well.
Some ME patients have the co-morbidity Postural Orthostatic Tachycardia Syndrome (POTS), and this syndrome is associated with hemodynamic instability.
This makes ME patients a vulnerable group of patients during anesthesia, so maybe a close monitoring with ALPE is a good idea?